CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Aug 27 (Reuters) - CASI Pharmaceuticals Inc CASI.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.